On October 2, 2025, Lifeway Foods, Inc. and Danone North America PBC announced a cooperation agreement that will resolve a pending litigation over Danone’s Stockholders’ Agreement and initiate an orderly refresh of Lifeway’s board of directors. The agreement states that the litigation will be stayed, Danone will abstain from voting on proposals in the current consent solicitation, and Danone will support the board’s recommended director candidates at the 2025 and 2026 annual meetings.
The agreement also requires Lifeway to evaluate capital allocation alternatives in light of the new governance arrangement, while Danone commits to not act by written consent in favor of any proposals from the Smolyansky-led consent solicitation. This arrangement provides clarity and stability for Lifeway’s governance structure and aligns Danone’s interests with the company’s long‑term strategy.
Julie Smolyansky, Lifeway’s Chairman, President and CEO, said the cooperation agreement “allows us to move forward with clarity and stability, while continuing to focus on what matters most: bringing probiotic‑rich foods to more families and creating value for our shareholders.” The deal is a significant governance milestone that could influence shareholder value and the company’s strategic direction.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.